Scandal-Hit Chinese Drug Maker Faces CSRC Fine

The CSRC's 600,000 yuan fine on Changsheng Biotechnology for falsifying data for a rabies vaccine form a small part of the 9.1 billion yuan it will have to pay.

To continue reading...

Get access today

Sign up for a free 2-week trial and get instant, unrestricted and unlimited access to Regulation Asia.


Already taken your free trial? Get in touch with our team and enquire about a subscription today. Select subscribe below to view our subscription packages or you can email us at [email protected] to discuss your options.


To Top
Share via
Copy link
Powered by Social Snap